{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:18:31Z","timestamp":1772889511386,"version":"3.50.1"},"reference-count":43,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spanish Ministry of Science, Innovation and Universities","award":["FPU16\/01209"],"award-info":[{"award-number":["FPU16\/01209"]}]},{"DOI":"10.13039\/501100002809","name":"Government of Catalonia","doi-asserted-by":"publisher","award":["DGRIS"],"award-info":[{"award-number":["DGRIS"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Government of Catalonia","doi-asserted-by":"publisher","award":["DGRIS 1_5"],"award-info":[{"award-number":["DGRIS 1_5"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Since the start of the COVID-19 outbreak, pharmaceutical companies and research groups have focused on the development of vaccines and antiviral drugs against SARS-CoV-2. Here, we apply a drug repurposing strategy to identify drug candidates that are able to block the entrance of the virus into human cells. By combining virtual screening with in vitro pseudovirus assays and antiviral assays in Human Lung Tissue (HLT) cells, we identify entrectinib as a potential antiviral drug.<\/jats:p>","DOI":"10.3390\/ijms222413592","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T20:37:27Z","timestamp":1639946247000},"page":"13592","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Entrectinib\u2014A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells"],"prefix":"10.3390","volume":"22","author":[{"given":"Alejandro","family":"Peralta-Garcia","sequence":"first","affiliation":[{"name":"Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences, Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University (UPF), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6233-8945","authenticated-orcid":false,"given":"Mariona","family":"Torrens-Fontanals","sequence":"additional","affiliation":[{"name":"Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences, Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University (UPF), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz Maciej","family":"Stepniewski","sequence":"additional","affiliation":[{"name":"Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences, Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University (UPF), 08003 Barcelona, Spain"},{"name":"InterAx Biotech AG, PARK InnovAARE, 5234 Villigen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-2429","authenticated-orcid":false,"given":"Judith","family":"Grau-Exp\u00f3sito","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Vall d\u2019Hebron Institut de Recerca (VHIR), Vall d\u2019Hebron Barcelona Hospital Campus, Vall d\u2019Hebron Hospital Universitari, 08035 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Perea","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Vall d\u2019Hebron Institut de Recerca (VHIR), Vall d\u2019Hebron Barcelona Hospital Campus, Vall d\u2019Hebron Hospital Universitari, 08035 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Ayinampudi","sequence":"additional","affiliation":[{"name":"InterAx Biotech AG, PARK InnovAARE, 5234 Villigen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Waldhoer","sequence":"additional","affiliation":[{"name":"InterAx Biotech AG, PARK InnovAARE, 5234 Villigen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"InterAx Biotech AG, PARK InnovAARE, 5234 Villigen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4427-9413","authenticated-orcid":false,"given":"Mar\u00eda J.","family":"Buz\u00f3n","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Vall d\u2019Hebron Institut de Recerca (VHIR), Vall d\u2019Hebron Barcelona Hospital Campus, Vall d\u2019Hebron Hospital Universitari, 08035 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6413-3812","authenticated-orcid":false,"given":"Meritxell","family":"Genesc\u00e0","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Vall d\u2019Hebron Institut de Recerca (VHIR), Vall d\u2019Hebron Barcelona Hospital Campus, Vall d\u2019Hebron Hospital Universitari, 08035 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-4449","authenticated-orcid":false,"given":"Jana","family":"Selent","sequence":"additional","affiliation":[{"name":"Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences, Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University (UPF), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"key":"ref_1","unstructured":"(2021, November 29). WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic Characterization of the 2019 Novel Human-Pathogenic Coronavirus Isolated from a Patient with Atypical Pneumonia after Visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CMR.00023-07","article-title":"Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection","volume":"20","author":"Cheng","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and Evolution of Pathogenic Coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional Assessment of Cell Entry and Receptor Usage for SARS-CoV-2 and Other Lineage B Betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.chom.2020.11.004","article-title":"Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a PH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains","volume":"28","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1080\/21505594.2021.1929800","article-title":"The Journey of SARS-CoV-2 in Human Hosts: A Review of Immune Responses, Immunosuppression, and Their Consequences","volume":"12","author":"Alshammary","year":"2021","journal-title":"Virulence"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19\u2014Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug Treatment Options for the 2019-New Coronavirus (2019-NCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci. Trends"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1080\/14756366.2021.1954919","article-title":"Supervised Molecular Dynamics (SuMD) Insights into the Mechanism of Action of SARS-CoV-2 Main Protease Inhibitor PF-07321332","volume":"36","author":"Pavan","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_11","unstructured":"Yavuz, S., and Komsuo\u011flu \u00c7elikyurt, F.I. (2021). Antiviral Treatment of COVID-19: An Update. Turk. J. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin Has Potent Preclinical Efficacy against SARS-CoV-2 by Targeting the Host Protein EEF1A","volume":"371","author":"White","year":"2021","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s40121-021-00525-4","article-title":"Efficacy of Bamlanivimab\/Etesevimab and Casirivimab\/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern","volume":"10","author":"Falcone","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Blaess, M., Kaiser, L., Sommerfeld, O., Csuk, R., and Deigner, H.-P. (2021). Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041797"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/cpt.2317","article-title":"Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study","volume":"110","author":"Hoertel","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.xcrm.2020.100142","article-title":"Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells","volume":"1","author":"Carpinteiro","year":"2020","journal-title":"Cell Rep. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","article-title":"Association between Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with COVID-19: Results from an Observational Study","volume":"26","author":"Hoertel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 Antiviral Drugs through Large-Scale Compound Repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.21873\/invivo.12134","article-title":"Ivermectin Docks to the SARS-CoV-2 Spike Receptor-Binding Domain Attached to ACE2","volume":"34","author":"Lehrer","year":"2020","journal-title":"In Vivo"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rensi, S., Altman, R.B., Liu, T., Lo, Y.-C., McInnes, G., Derry, A., and Keys, A. (2020). Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells. ChemRxiv.","DOI":"10.26434\/chemrxiv.12009582"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2016-09-736892","article-title":"Identification of Apilimod as a First-in-Class PIKfyve Kinase Inhibitor for Treatment of B-Cell Non-Hodgkin Lymphoma","volume":"129","author":"Gayle","year":"2017","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and Its Immune Cross-Reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Baranov, M.V., Bianchi, F., and van den Bogaart, G. (2021). The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19. Cells, 10.","DOI":"10.3390\/cells10010030"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Grau-Exp\u00f3sito, J., Perea, D., Suppi, M., Massana, N., Vergara, A., Soler, M.J., Trinite, B., Blanco, J., Garc\u00eda-P\u00e9rez, J., and Alcam\u00ed, J. (2021). Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells. bioRxiv.","DOI":"10.1101\/2021.04.21.440731"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Meneses-Lorente, G., Fowler, S., Guerini, E., Kowalski, K., Chow-Maneval, E., Yu, L., Mercier, F., Ullah, M., Umehara, K., and Brink, A. (2021). In Vitro and Clinical Investigations to Determine the Drug-Drug Interaction Potential of Entrectinib, a Small Molecule Inhibitor of Neurotrophic Tyrosine Receptor Kinase (NTRK). Investig. New Drugs.","DOI":"10.1007\/s10637-021-01156-9"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2011.01.016","article-title":"Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor","volume":"38","author":"Blay","year":"2011","journal-title":"Semin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/bcpt.13537","article-title":"The Tyrosine Kinase Inhibitor Nilotinib Inhibits SARS-CoV-2 in Vitro","volume":"128","author":"Cagno","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1021\/acs.jcim.0c00821","article-title":"Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server","volume":"60","author":"Xu","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/jgv.0.001047","article-title":"Coronavirus S Protein-Induced Fusion Is Blocked Prior to Hemifusion by Abl Kinase Inhibitors","volume":"99","author":"Sisk","year":"2018","journal-title":"J. Gen. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1128\/JVI.01429-16","article-title":"Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion","volume":"90","author":"Coleman","year":"2016","journal-title":"J. Virol."},{"key":"ref_32","unstructured":"Shaw, D.E. (2021, August 30). Research, Molecular Dynamics Simulations Related to SARS-CoV-2. D.E. Shaw Research Technical Data. Available online: http:\/\/www.deshawresearch.com\/resources_sarscov2.html."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Venkatakrishnan, A.J., Fonseca, R., Ma, A.K., Hollingsworth, S.A., Chemparathy, A., Hilger, D., Kooistra, A.J., Ahmari, R., Babu, M.M., and Kobilka, B.K. (2019). Uncovering Patterns of Atomic Interactions in Static and Dynamic Structures of Proteins. bioRxiv, 840694.","DOI":"10.1101\/840694"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: A Comprehensive Resource for in Silico Drug Discovery and Exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: New Data Content and Improved Web Interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15\u2014Ligand Discovery for Everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization and Multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref_39","unstructured":"(2021). Schr\u00f6dinger Release 2021-3: LigPrep, Schr\u00f6dinger, LLC. Available online: https:\/\/www.schrodinger.com\/products\/ligprep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An Open Chemical Toolbox","volume":"3","author":"Banck","year":"2011","journal-title":"J. Cheminform."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational Protein-Ligand Docking and Virtual Drug Screening with the AutoDock Suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Torrens-Fontanals, M., Peralta-Garc\u00eda, A., Talarico, C., Guix\u00e0-Gonz\u00e1lez, R., Giorgino, T., and Selent, J. (2021). SCoV2-MD: A Database for the Dynamics of the SARS-CoV-2 Proteome and Variant Impact Predictions. Nucleic Acids Res., gkab977.","DOI":"10.1093\/nar\/gkab977"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual Molecular Dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/24\/13592\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:51:39Z","timestamp":1760169099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/24\/13592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,18]]},"references-count":43,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222413592"],"URL":"https:\/\/doi.org\/10.3390\/ijms222413592","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.07.459123","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,18]]}}}